Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorLoyola University

About this trial

The goal of this clinical trial is to learn if there is a difference in morphine requirements in patients after upper extremity surgeries including shoulder arthroscopy. The main question it aims to answer is whether there is a difference between Interscalene brachial plexus blocks with the addition of buprenorphine, dexamethasone, and clonidine and the same block without the adjuvant.

Eligibility criteria

Qualifiers

Patients ≥ 18 years old

Patients undergoing shoulder arthroscopy

Patients willing to participate and sign informed consent

Disqualifiers

Severe COPD/other contraindication to general anesthesia

Patient with a weight of less than 60 kg

Dementia, not alert or oriented to person, place, or time

Chronic pain patient with daily opioid use at home.

Trial design

Treatments tested in this trial

  • Interscalene block with the addition of buprenorphine, clonidine, dexamethasone
  • Interscalene block with buprenorphine alone

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators